Further, we do cite Sacher et al3 which describes the successful validation of the PrimePCR endothelial growth factor receptor gene (EGFR) and KRAS assays on circulating tumour DNA (ctDNA) against matched tumour specimens. Here, KRAS is linked to neoplasm.